Cited by

• Individual contributions of mutant protease and reverse transcriptase to viral infectivity, replication, and protein maturation of antiretroviral drug-resistant human immunodeficiency virus type 1.

  Bleiber G, Munoz M, Ciuffi A, Meylan P, Telenti A. Bleiber G, et al. J Virol. 2001 Apr;75(7):3291-300. doi: 10.1128/JVI.75.7.3291-3300.2001. J Virol. 2001. PMID: 11238855 Free PMC article.
• Correlations of soluble interleukin-2 and tumor necrosis factor type II receptors with immunologic and virologic responses under HAART.

  Bonnet F, Savès M, Morlat PH, Droz C, Chêne G, Peuchant E, Bernard N, Lacoste D, Salamon R, Beylot J. Bonnet F, et al. J Clin Immunol. 2002 Mar;22(2):75-82. doi: 10.1023/a:1014475618504. J Clin Immunol. 2002. PMID: 11998896
• Systemic Cytokine Levels Do Not Predict CD4(+) T-Cell Recovery After Suppressive Combination Antiretroviral Therapy in Chronic Human Immunodeficiency Virus Infection.

  Norris PJ, Zhang J, Worlock A, Nair SV, Anastos K, Minkoff HL, Villacres MC, Young M, Greenblatt RM, Desai S, Landay AL, Gange SJ, Nugent CT, Golub ET, Keating SM. Norris PJ, et al. Open Forum Infect Dis. 2016 Feb 8;3(1):ofw025. doi: 10.1093/ofid/ofw025. eCollection 2016 Jan. Open Forum Infect Dis. 2016. PMID: 26966697 Free PMC article.
• Factors associated with poor immunologic response to virologic suppression by highly active antiretroviral therapy in HIV-infected women.

  Vaamonde CM, Hoover DR, Anastos K, Tan T, Shi Q, Gao W, Kovacs A, Cohen M, DeHovitz J, Glesby MJ. Vaamonde CM, et al. AIDS Res Hum Retroviruses. 2006 Mar;22(3):222-31. doi: 10.1089/aid.2006.22.222. AIDS Res Hum Retroviruses. 2006. PMID: 16545008 Free PMC article.
• Repositioning HIV protease inhibitors as cancer therapeutics.

  Bernstein WB, Dennis PA. Bernstein WB, et al. Curr Opin HIV AIDS. 2008 Nov;3(6):666-75. doi: 10.1097/COH.0b013e328313915d. Curr Opin HIV AIDS. 2008. PMID: 19373040 Free PMC article.